Dtsch Med Wochenschr 2017; 142(08): 579-585
DOI: 10.1055/s-0042-124411
Dossier
© Georg Thieme Verlag KG Stuttgart · New York

Operative und interventionelle Therapie der Mitralinsuffizienz

Surgical and Interventional Therapy of Mitral Valve Regurgitation
Wolfgang Schillinger
,
Miriam Puls
,
Bernhard C. Danner
Further Information

Publication History

Publication Date:
21 April 2017 (online)

Abstract

Depending from the etiology of mitral valve pathology and surgical risk, mitral valve surgery is the therapy of choice for most degenerative mitral valve diseases. In isolated secondary mitral valve regurgitation, the indication for interventional or conservative therapy becomes more important. In severe left ventricular dysfunction heart transplantation has to be taken into consideration. If relevant coronary artery disease is present and bypass surgery is indicated, mitral valve surgery is mandatory in severe regurgitation and is subject to a benefit-risk evaluation in moderate regurgitation. Decision pathways take multiple aspects into consideration (fig. 4) like comorbidities and physical status of the patient as well as anatomy of the mitral valve and pathology of regurgitation. The choice of they should found after inspection of the patient by a multidisciplinary team consisting of a cardiologist, a cardiac surgeon, an echocardiographer and a cardiac anesthesiologist.

Die operative und interventionelle Therapie der Mitralinsuffizienz zeigt seit Jahren gute Ergebnisse und hat in den vergangenen Jahren weitere Fortschritte gemacht. Das operative Trauma konnte minimiert werden und minimalinvasive Techniken wurden immer weiter verfeinert [1]. Daneben wurden in zunehmendem Maße kathetetergestützte Verfahren entwickelt mit dem Ziel, Patienten mit besonders hohem operativem Risiko und inoperablen Patienten eine Therapieoption zu eröffnen [2].

 
  • Literatur

  • 1 Gammie JS. Sheng SB. Griffith BP. et al. Trends in mitral valve surgery in the United States: Results from the society of thoracic surgeons adult cardiac database. Ann Thorac Surg 2009; 78: 1431-1439
  • 2 La Canna G. Denti P. Buzzatti N. et al. Recent development in percutaneous mitral valve treatment. Expert Rev Cardiovasc Ther 2016; 14: 217-228
  • 3 Nkomo VT. Gardin JM. Skelton TN. et al. Burden of valvular heart diseases: A population-based study. Lancet 2006; 368: 1005-1011
  • 4 Mirabel M. Iung B. Baron G. et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?. Eur Heart J 2007; 28: 1358-1365
  • 5 Lillehei CW. Gott VL. Dewall RA. et al. Surgical correction of pure mitral insufficiency by annuloplasty under direct vision. J Lancet 1957; 77: 446-449
  • 6 Glower DD. Surgical approaches to mitral regurgitation. J Am Coll Cardiol 2012; 60: 1315-1322
  • 7 Spoor MT. Geltz A. Bolling SF. Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. Circulation 2006; 114: I67-71
  • 8 Braunberger E. Deloche A. Berrebi A. et al. A Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation 2001; 104: I8-11
  • 9 Maisano F. La Canna G. Colombo A. et al. The evolution from surgery to percutaneous mitral valve interventions: The role of edge-to-edge technique. J Am Coll Cardiol 2011; 58: 2174-2182
  • 10 Ibrahim M. Rao C. Athanasiou T. Artificial chordae for degenerative mitral valve disease: critical analysis of current techniques. Interact Cardiovasc Thorac Surg 2012; 15: 1019-1032
  • 11 Ragnarsson S. Sjögren J. Sanchez R. et al. Polytetrafluoroethylene neochordae is noninferior to leaflet resection in repair of isolated posterior mitral leaflet prolapse: a multicentre study. Interact Cardiovasc Thorac Surg 2014; 19: 577-583
  • 12 Perier P. Hohenberger W. Lakew F. et al. Toward a new paradigm for the reconstruction of posterior leaflet prolapse: midterm results of the "respect rather than resect" approach. Ann Thorac Surg 2008; 86: 718-725
  • 13 Danner B. Bräuer A. Teucher N. et al. Beating heart mitral valve chordae implantation in severe mitral degenerative regurgitation. Thorac Cardiovasc Surg 2016 64.
  • 14 Rucinskas K. Janusauskas V. Zakarkaite D. et al. Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: early results of a single-center experience. J Thorac Cardiovasc Surg 2014; 147: 95-99
  • 15 Dörge H. Schmitto JD. Liakopoulos O. et al. Extended myectomy for hypertrophic obstructive cardiomyopathy after failure or contraindication of septal ablation or with combined surgical procedures. Thorac Cardiovasc Surg 2004; 52: 344-348
  • 16 Eikelboom JW. Connolly SJ. Brueckmann M. et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 2013; 369: 1206-1214
  • 17 Bolling SF. Li S. O’Brien SM. et al. Predictors of mitral valve repair: clinical and surgeon factors. Ann Thorac Surg 2010; 90: 1904-1912
  • 18 Vahanian A. Alfieri O. Andreotti F. et al. Guidelines on the management of valvular heart disease. Eur Heart J 2012; 33: 2451-2496
  • 19 Nickenig G. Mohr FW. et al. Konsensus der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung – und der Deutschen Gesellschaft für Thorax-, Herz- und Gefäßchirurgie zur Behandlung der Mitralklappeninsuffizienz. Kardiologe 2013; 7: 76-90
  • 20 Nishimura RA. Otto CM. Bonow RO. et al. 2014 AHA/ACC guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: e57-e185
  • 21 Dayan V. Soca G. Cura L. et al. Similar survival after mitral valve replacement or repair for ischemic mitral regurgitation: a meta-analysis. Ann Thorac Surg 2014; 97: 758-765
  • 22 Michler RE. Smith PK. Parides MK. et al. Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. N Engl J Med 2016; 374: 1932-1941
  • 23 Maisano F. Torracca L. Oppizzi M. et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg 1998; 13: 240-245
  • 24 Feldman T. Foster E. Glower DD. et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364: 1395-1406
  • 25 Feldman T. Kar S. Emariah S. et al. Randomized comparison of percutaneous repair or surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol 2015; 66: 2844-2854
  • 26 Puls M. Lubos E. Boekstegers P. et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: Results from the German transcatheter mitral valve interventions registry. Eur Heart J 2016; 37: 703-712
  • 27 Siminiak T. Wu JC. Haude M. et al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail 2012; 14: 931-938
  • 28 Lipiecki J. Siminiak T. Sievert H. et al. Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trial. Open Heart 2016; 3: e000411
  • 29 Nickenig G. Hammerstingl C. Schueler R. et al. Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System. JACC Cardiovasc Interv 2016; 9: 2039-2047
  • 30 Søndergaard L. De Backer O. Franzen OW. et al. First-in-Human Case of Transfemoral CardiAQ Mitral Valve Implantation. Circ Cardiovasc Interv 2015; 8: e002135
  • 31 Dvir D. Webb J. Mitral valve-in-valve and valve-in-ring: technical aspects and procedural outcomes. EuroIntervention 2016; 12: Y93-Y96